REGULATORY INTELLIGENCE·Recall
FDA Class I Recall: Benzene Contamination Triggers Urgent Action for Insight Pharmaceuticals' Americaine Spray
Insight Pharmaceuticals LLC faces an FDA Class I recall for 34,704 cans of Americaine Benzocaine Topical Anesthetic Spray due to benzene contamination. This critical event, initiated December 21, 2023, necessitates immediate action from procurement and regulatory teams. Businesses must reassess supplier quality for topical APIs and finished products, especially those manufactured internationally, to mitigate severe health risks and maintain compliance.
90-Day Activity